ClinicalTrials.gov
ClinicalTrials.gov Menu

Bleeding Symptoms of Carriers of Hemophilia A and B

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01029808
Recruitment Status : Completed
First Posted : December 10, 2009
Last Update Posted : October 19, 2016
Sponsor:
Information provided by (Responsible Party):
Anna Olsson, Sahlgrenska University Hospital, Sweden

Brief Summary:
To collect and analyze data on female carriers of severe and moderate hemophilia A and B.

Condition or disease
Hemophilia

Study Type : Observational
Actual Enrollment : 126 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Bleeding Symptoms of Carriers of Hemophilia A and B
Study Start Date : December 2009
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bleeding Hemophilia




Primary Outcome Measures :
  1. Bleeding tendency in carriers of severe and moderate haemophilia compared to a control group. [ Time Frame: Five years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Carriers of severe and moderate hemophilia A and B
Criteria

Inclusion Criteria:

  • Female carriers of hemophilia A and B.

Exclusion Criteria:

  • Pregnancy.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01029808


Locations
Sweden
Sahlgrenska university hospital
Göteborg, Sweden, 41345
Sponsors and Collaborators
Sahlgrenska University Hospital, Sweden
Investigators
Study Chair: Fariba Baghaei, MD PhD

Publications of Results:
Responsible Party: Anna Olsson, MD, Sahlgrenska University Hospital, Sweden
ClinicalTrials.gov Identifier: NCT01029808     History of Changes
Other Study ID Numbers: VGAO002
First Posted: December 10, 2009    Key Record Dates
Last Update Posted: October 19, 2016
Last Verified: October 2016

Keywords provided by Anna Olsson, Sahlgrenska University Hospital, Sweden:
carriers of hemophilia

Additional relevant MeSH terms:
Hemophilia A
Blood Coagulation Disorders, Inherited
Blood Coagulation Disorders
Hematologic Diseases
Coagulation Protein Disorders
Hemorrhagic Disorders
Genetic Diseases, Inborn
Factor VIII
Coagulants